Found: 47
Select item for more details and to access through your institution.
Advances in understanding pectin methylesterase inhibitor in kiwi fruit: an immunological approach.
- Published in:
- Planta: An International Journal of Plant Biology, 2011, v. 233, n. 2, p. 287, doi. 10.1007/s00425-010-1307-6
- By:
- Publication type:
- Article
Improved functionalization of oleic acid-coated iron oxide nanoparticles for biomedical applications.
- Published in:
- Journal of Nanoparticle Research, 2012, v. 14, n. 9, p. 1, doi. 10.1007/s11051-012-1100-5
- By:
- Publication type:
- Article
Corrigendum: PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin.
- Published in:
- Nature Medicine, 2015, v. 21, n. 5, p. 537, doi. 10.1038/nm0515-537a
- By:
- Publication type:
- Article
Corrigendum: PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin.
- Published in:
- Nature Medicine, 2014, v. 20, n. 10, p. 1217, doi. 10.1038/nm1014-1217b
- By:
- Publication type:
- Article
PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin.
- Published in:
- Nature Medicine, 2014, v. 20, n. 7, p. 741, doi. 10.1038/nm.3552
- By:
- Publication type:
- Article
His374 of wheat endoxylanase inhibitor TAXI-I stabilizes complex formation with glycoside hydrolase family 11 endoxylanases.
- Published in:
- FEBS Journal, 2005, v. 272, n. 22, p. 5872, doi. 10.1111/j.1742-4658.2005.04987.x
- By:
- Publication type:
- Article
Combining Therapeutic Drug Monitoring with Biosimilars, a Strategy to Improve the Efficacy of Biologicals for Treating Inflammatory Bowel Diseases at an Affordable Cost.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 61, doi. 10.1159/000449085
- By:
- Publication type:
- Article
Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic Information.
- Published in:
- AAPS Journal, 2019, v. 21, n. 1, p. 1, doi. 10.1208/s12248-018-0282-x
- By:
- Publication type:
- Article
Validation of a Drug-Resistant Anti-Adalimumab Antibody Assay to Monitor Immunogenicity in the Presence of High Concentrations of Adalimumab.
- Published in:
- AAPS Journal, 2017, v. 19, n. 2, p. 468, doi. 10.1208/s12248-016-0018-8
- By:
- Publication type:
- Article
Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®.
- Published in:
- AAPS Journal, 2017, v. 19, n. 1, p. 161, doi. 10.1208/s12248-016-9981-3
- By:
- Publication type:
- Article
Heterobifunctional PEG Ligands for Bioconjugation Reactions on Iron Oxide Nanoparticles.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109475
- By:
- Publication type:
- Article
The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseases.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 10, p. 3776, doi. 10.1111/bcp.14785
- By:
- Publication type:
- Article
Modelling of the relationship between infliximab exposure, faecal calprotectin and endoscopic remission in patients with Crohn's disease.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 1, p. 106, doi. 10.1111/bcp.14364
- By:
- Publication type:
- Article
Optimising infliximab induction dosing for patients with ulcerative colitis.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 4, p. 782, doi. 10.1111/bcp.13859
- By:
- Publication type:
- Article
Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth.
- Published in:
- Oncogene, 2004, v. 23, n. 41, p. 6986, doi. 10.1038/sj.onc.1207859
- By:
- Publication type:
- Article
Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 101, doi. 10.2147/CPAA.S138414
- By:
- Publication type:
- Article
Recurrent pericarditis as an extra‐intestinal manifestation of ulcerative colitis in a 14‐year‐old girl.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Preemptive Dose Optimization Using Therapeutic Drug Monitoring for Biologic Therapy of Crohn's Disease: Avoiding Failure While Lowering Costs?
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Achieving Mucosal Healing in Inflammatory Bowel Diseases: Which Drug Concentrations Need to Be Targeted?
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 945, doi. 10.1002/cpt.1609
- By:
- Publication type:
- Article
Pharmacokinetics of anti-TNF monoclonal antibodies in inflammatory bowel disease: Adding value to current practice.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, p. S39, doi. 10.1002/jcph.374
- By:
- Publication type:
- Article
Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Two-Step Directional Surface Modification of Iron Oxide Nanoparticles with Protected Siloxanes.
- Published in:
- ChemPlusChem, 2015, v. 80, n. 1, p. 50, doi. 10.1002/cplu.201402283
- By:
- Publication type:
- Article
Accounting for Pharmacokinetic Variability of Certolizumab Pegol in Patients with Crohn's Disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn's disease.
- Published in:
- Drug Testing & Analysis, 2018, v. 10, n. 3, p. 592, doi. 10.1002/dta.2250
- By:
- Publication type:
- Article
Antibody-modified iron oxide nanoparticles for efficient magnetic isolation and flow cytometric determination of L. pneumophila.
- Published in:
- Microchimica Acta, 2015, v. 182, n. 7/8, p. 1439, doi. 10.1007/s00604-015-1466-z
- By:
- Publication type:
- Article
The association between etanercept serum concentration and psoriasis severity is highly age-dependent.
- Published in:
- Clinical Science, 2017, v. 131, n. 11, p. 1179, doi. 10.1042/CS20170048
- By:
- Publication type:
- Article
Mucosal IL13RA2 expression predicts nonresponse to anti‐TNF therapy in Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 5, p. 572, doi. 10.1111/apt.15126
- By:
- Publication type:
- Article
Letter: overcoming secondary loss of response to infliximab—it is not the drug, it is how you use it! Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 9, p. 1029, doi. 10.1111/apt.14974
- By:
- Publication type:
- Article
Influence of early adalimumab serum levels on immunogenicity and long‐term outcome of anti‐TNF naive Crohn's disease patients: the usefulness of rapid testing.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 7, p. 731, doi. 10.1111/apt.14943
- By:
- Publication type:
- Article
Validation of a sample pretreatment protocol to convert a drug-sensitive into a drug-tolerant anti-infliximab antibody immunoassay.
- Published in:
- Drug Testing & Analysis, 2017, v. 9, n. 2, p. 243, doi. 10.1002/dta.1968
- By:
- Publication type:
- Article
Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease: A Cohort Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Immunogenicity of biologics in inflammatory bowel disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2018, v. 11, p. 1, doi. 10.1177/1756283X17750355
- By:
- Publication type:
- Article
Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab Concentrations.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 6, p. 988, doi. 10.1093/ecco-jcc/jjaa239
- By:
- Publication type:
- Article
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD Patients.
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 3, p. 332, doi. 10.1093/ecco-jcc/jjz151
- By:
- Publication type:
- Article
Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 11, p. 1401, doi. 10.1093/ecco-jcc/jjz080
- By:
- Publication type:
- Article
Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 10, p. 1248, doi. 10.1093/ecco-jcc/jjz050
- By:
- Publication type:
- Article
Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 7, p. 864, doi. 10.1093/ecco-jcc/jjz008
- By:
- Publication type:
- Article
Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 11, p. 1316, doi. 10.1093/ecco-jcc/jjy111
- By:
- Publication type:
- Article
Blocking α<sub>4</sub> β<sub>7</sub> Integrin Through Vedolizumab: Necessary but not Sufficient?
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 8, p. 903, doi. 10.1093/ecco-jcc/jjx033
- By:
- Publication type:
- Article
Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 1, p. 53, doi. 10.1093/ecco-jcc/jjw122
- By:
- Publication type:
- Article
Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 1, p. 1, doi. 10.1093/ecco-jcc/jjw141
- By:
- Publication type:
- Article
Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab.
- Published in:
- Journal of Crohn's & Colitis, 2016, v. 10, n. 9, p. 1015, doi. 10.1093/ecco-jcc/jjw067
- By:
- Publication type:
- Article
Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2016, v. 10, n. 5, p. 575, doi. 10.1093/ecco-jcc/jjv241
- By:
- Publication type:
- Article
Loss of Response to Anti-TNF Monoclonal Antibodies: Mechanisms, Assessment, and Management.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 1, p. 1
- By:
- Publication type:
- Article
Immunogenicity is not the driving force of treatment failure in vedolizumab‐treated inflammatory bowel disease patients.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 7, p. 1175, doi. 10.1111/jgh.14584
- By:
- Publication type:
- Article
Inhibition of plasmin-mediated TAFI activation may affect development but not progression of abdominal aortic aneurysms.
- Published in:
- PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0177117
- By:
- Publication type:
- Article
Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2013, v. 108, n. 6, p. 962, doi. 10.1038/ajg.2013.12
- By:
- Publication type:
- Article